Showcase

公司名稱 Company Name

中港醫藥科技有限公司
SINO-HK PHARM TECHNOLOGY LIMITED
公司簡介 Company Background
中港醫藥科技專注研發全球首創治療良性前列腺增生 1.1 類中藥創新藥。針對現有藥物的副作用與局限性，我們以經典方劑為基石，研發更安全、精準的現代中成藥，提升患者長期用藥的依從性。公司正全力推進產品的臨床試驗，致力為全球數億中老年男性提供更優質的治療選擇，同時優化醫療資源配置，切實改善患者的生活品質。
Sino-Hong Kong Pharma Technology specializes in the R&D of a world-first Class 1.1 innovative Chinese medicine for Benign Prostatic Hyperplasia (BPH).By leveraging classic herbal formulas as a foundation, we develop safer, more precise modern Chinese proprietary medicines that address the side effects and limitations of current treatments. Our mission is to enhance long-term patient compliance and improve quality of life for hundreds of millions of aging men worldwide.Currently, the company is accelerating clinical trials for our lead product, aiming to optimize medical resource allocation and provide superior therapeutic alternatives on a global scale.
陳列產品之簡介 Description of displayed product
【前列康膠囊】是源於經典方劑「前列腺湯」創新研發的 1.1 類中藥復方製劑，針對良性前列腺增生核心病機，具備清熱化濕、祛瘀散結、益氣活血等功效。憑藉中藥「多成分、多靶點」的優勢，實現個體化的精準治療。經臨床現代藥學與毒理學研究驗證，展現出卓越的安全性與有效性，為全球 BPH 患者提供治療新方案。
[Qianliekang Capsule] is an innovative Class 1.1 traditional Chinese medicine (TCM) compound derived from the classic “Qian Lie Xian Herbal Soup.” Specifically formulated to target the core pathogenesis of Benign Prostatic Hyperplasia (BPH). It effectively clears heat, dispels dampness, removes stasis, and promotes blood circulation.By leveraging the unique “multi-component, multi-target” advantages of TCM, the capsule enables individualized precision therapy. Modern pharmacological and toxicological studies have validated its superior safety and efficacy.As a breakthrough therapeutic solution, [Qianliekang Capsule] offers a high-quality, reliable alternative for BPH patients worldwide, significantly improving long-term health outcomes.
公司產品 Company products